Patent · US Active

Polycistronic expression system for bacteria

US10988770B2 · kind B2 · utility

0Cited by

22References

44Claims

0Family size

Assignee

INTREXON ACTOBIOTICS N.V. · BE

Inventors

Klaas Vandenbroucke · Zevergem, BE
Karolien Van Huynegem · Asper, BE
Lothar Steidler · Lokeren, BE

Key dates

Filing date	Feb 15, 2018
Grant date	Apr 27, 2021
Priority date	—
Expiry date	Mar 27, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N15/74
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to polycistronic expression in gram-positive bacterium and in particular concerns polycistronic expression units comprising one or more gene endogenous to the gram-positive bacterium transcriptionally coupled to one or more genes exogenous to the bacterium.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.